Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 10,850 | 11,555 | 10,131 | 13,490 | 10,921 |
| Cost of Goods | 6,468 | 6,946 | 6,795 | 9,967 | 7,175 |
| Gross Profit | 4,382 | 4,609 | 3,336 | 3,523 | 3,746 |
| Operating Expenses | 5,545 | 8,775 | 8,657 | 9,567 | 7,618 |
| Operating Income | -695 | -3,220 | -4,526 | -5,077 | -3,697 |
| Interest Expense | 605 | 586 | 622 | 603 | 598 |
| Other Income | -116 | 1,028 | -1,318 | 338 | -279 |
| Pre-tax Income | -1,416 | -2,778 | -6,466 | -5,342 | -4,574 |
| Income Tax | 12 | 20 | 19 | -16 | 15 |
| Net Income Continuous | -1,428 | -2,798 | -6,485 | -5,326 | -4,589 |
| Net Income | $-1,428 | $-2,798 | $-6,485 | $-5,326 | $-4,589 |
| EPS Basic Total Ops | -0.04 | -0.08 | -0.36 | 24.88 | -10.35 |
| EPS Basic Continuous Ops | -0.04 | -0.08 | -0.36 | 14.51 | -3.89 |
| EPS Diluted Total Ops | -0.04 | -0.08 | -0.36 | 24.88 | -10.35 |
| EPS Diluted Continuous Ops | -0.04 | -0.08 | -0.36 | 14.51 | -3.89 |
| EPS Diluted Before Non-Recurring Items | -0.04 | -0.08 | -0.36 | -1.76 | -3.89 |
| EBITDA(a) | $67 | $-2,453 | $-3,741 | $-4,306 | $-3,031 |